Table 2. Risk estimates of alcohol consumption with BE by geographic region, gender and control types.
| No. of studies | No. of cases | Relative risk (95% CI) | Heterogeneity |
Publication bias |
|||
|---|---|---|---|---|---|---|---|
| p | I2 | Begg’s test | Egger’s test | ||||
| Western countries | 17 | 40993 | 0.90 (0.79–1.01) | 0.56 | 0.00% | 1.00 | 0.99 |
| Asia countries | 1 | 463 | 1.12 (0.49–1.85) | NA | NA | NA | NA |
| MEN | 6 | 7593 | 0.97 (0.80–1.14) | 0.90 | 0.00% | 0.81 | 0.77 |
| WOMEN | 5 | 7130 | 0.71 (0.50–0.92) | 0.29 | 11.7% | 1.00 | NA |
| Population control | 5 | 30176 | 0.90 (0.73–1.07) | 0.83 | 0.0% | 1.00 | 0.95 |
| Inflammation control | 8 | 3347 | 0.86 (0.70–1.02) | 0.18 | 35.5% | 0.22 | 0.63 |
| Endoscopic negative control | 4 | 3683 | 1.13 (0.74–1.52) | 0.96 | 0.00% | 1.00 | NA |
NA, not applicable.